These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 5106836

  • 1. Depot medroxyprogesterone acetate (Depo-Provera) as a contraceptive preparation.
    Bloch B.
    S Afr Med J; 1971 Jul 17; 45(28):777-80. PubMed ID: 5106836
    [No Abstract] [Full Text] [Related]

  • 2. Long acting injectable hormonal contraceptives.
    Fraser IS.
    Clin Reprod Fertil; 1982 Mar 17; 1(1):67-88. PubMed ID: 6226351
    [Abstract] [Full Text] [Related]

  • 3. Depo Provera: a review.
    Nash HA.
    Contraception; 1975 Oct 17; 12(4):377-93. PubMed ID: 1104254
    [No Abstract] [Full Text] [Related]

  • 4. [Contraception using 3-monthly injections of Depo-Provera].
    Revaz C, Welti H, Dettling A.
    Gynakol Rundsch; 1978 Oct 17; 18(3-4):183-92. PubMed ID: 569623
    [No Abstract] [Full Text] [Related]

  • 5. Effects of depo-medroxyprogesterone acetate as a contraceptive agent.
    Powell LC, Seymour RJ.
    Am J Obstet Gynecol; 1971 May 01; 110(1):36-41. PubMed ID: 5573607
    [No Abstract] [Full Text] [Related]

  • 6. Depo-provera: contraceptive risk?
    Rosenfield A.
    Hastings Cent Rep; 1980 Apr 01; 10(2):4. PubMed ID: 6445344
    [Abstract] [Full Text] [Related]

  • 7. Experience with depo-medroxyprogesterone acetate (Depo-Provera) as a contraceptive agent.
    Jeppsson S.
    Acta Obstet Gynecol Scand; 1972 Apr 01; 51(3):257-63. PubMed ID: 5072161
    [No Abstract] [Full Text] [Related]

  • 8. [Depo-Provera--antineoplastic agents which is also a contraceptive].
    Tylleskär J.
    Jordemodern; 1988 Mar 01; 101(3):55-8. PubMed ID: 2967271
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Injectable long-acting progestogen contraception: a neglected modality.
    Rosenfield AG.
    Am J Obstet Gynecol; 1974 Oct 15; 120(4):537-48. PubMed ID: 4606673
    [No Abstract] [Full Text] [Related]

  • 13. A comprehensive review of injectable contraception with special emphasis on depot medroxyprogesterone acetate.
    Fraser IS, Weisberg E.
    Med J Aust; 1981 Jan 24; 1(SP1):3-19. PubMed ID: 6453269
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Use of drugs and intrauterine devices for birth control.
    Meeker CI.
    N Engl J Med; 1969 May 08; 280(19):1058-60. PubMed ID: 4180710
    [Abstract] [Full Text] [Related]

  • 17. Depo-Provera. Controversial contraceptive wins approval from FDA panel.
    Stone R.
    Science; 1992 Jun 26; 256(5065):1754. PubMed ID: 1535454
    [No Abstract] [Full Text] [Related]

  • 18. [On the clinical use of depomedroxyprogesterone acetate as an antiovulatory and ovariostatic agent, especially in lactating puerperas].
    Mengaldo R.
    Minerva Ginecol; 1974 Jun 26; 26(6):358-66. PubMed ID: 4858750
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Injectable contraception.
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP.
    IPPF Med Bull; 1980 Dec 26; 14(6):1-3. PubMed ID: 12310087
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.